@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C0020456 "hyperglycemia"; ns1:C0020488 "sodium retention"; ns1:C4552833 "hyperglycemia"; ns1:C4722157 "sodium retention" . rdf:predicate ns2:TRIPLE_UID:9q3fo3a5-TRIPLE-ABSTRACT-12 "induce" . rdf:subject ns1:C0001617 "corticosteroid"; ns1:C0011777 "dexamethasone"; ns1:C3536709 "corticosteroid" . rdfs:Triple-UID ns3:TRIPLE_UID:9q3fo3a5-TRIPLE-ABSTRACT-12 "9q3fo3a5-TRIPLE-ABSTRACT-12" . rdfs:sentence rdfs:label "Importantly, the anti-inflammatory corticosteroid dexamethasone may be detrimental by impairing viral clearance and inducing hyperglycemia and sodium retention, hence possibly being deleterious for diabetics and hypertensive patients, two major COVID-19 risk groups." . rdfs:triple rdfs:label "the anti - inflammatory corticosteroid dexamethasone inducing hyperglycemia and sodium retention" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:46:03.230191"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "VmpJidD5/+GdjXcEojfGg1QcfyReKAcYkmI4NQjoa1SAmzEWaFVMnqdAL2ZRsfEQqH3eyVR7xAZHd7NmHsQDXWDWfwqOk4CG2WEFVRZ31okcsZbhoVDkCtzNGr5ymAFb5x8YZZ8pw9jXWI/i58VhD3AzluGgjsFE3ipgL6EA23M="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:46:03.230191"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }